An interventional study of Positively framed FOP labels (present versus absent) x Price (high versus low) and Graded FOP labels (no label vs. high rating (grade A) vs. low rating (grade D)) x Price (average vs. premium) in Consumer Behavior, sponsored by Duke-NUS Graduate Medical School. Not yet recruiting. Open to participants aged Up to 65 Years. Per ClinicalTrials.gov, last updated 2025-09-23.
Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The global epidemic of obesity and chronic diseases has led to widespread use of front-of-package (FOP) nutrition labels. While existing research has established a link between FOP labels and consumer choices, the interplay between product types, consumer perceptions, and label effectiveness is underexplored. This study examines: 1) whether consumers perceive healthier food item as more expensive when healthiness is less obvious; 2) how FOP labels mediate the relationship among product characteristics, price, and consumer's belief about food healthiness and price on choices; and 3) whether food choice changes given a price, with and without FOP labels, are more prominent for products where the perceived healthiness by consumers significantly differs from label indications. The investigators will conduct experiments with online panelists in Korea and Singapore in two settings: restaurant menus and grocery items. Results will inform more impactful nutritional information policies for healthier food choices and improved population health.
The investigators will conduct experiments in both Korea and Singapore, focusing on two settings with various food items: restaurant menu choices and grocery item selections. For each item, investigators will elicit consumers' prior belief about its healthiness. Our research builds upon the work of Haws et al. (2017), which demonstrated that US consumers tend to overgeneralize their belief about "expensive=healthy" to product categories where it is not true. This tendency potentially biases perceptions of healthy foods. The investigators aim to test this "expensive=healthy" intuition and its impact on food choice, with and without FOP labels, in Asian contexts. The investigators hypothesize that absent FOP labels, consumers will infer healthiness from price information (i.e., this product is expensive, so it must be healthy) and that providing FOP labels will reduce the reliance on this inference. The investigators also hypothesize that such effects of FOP labels are more prominent for products where the perceived healthiness by consumers significantly differs from the healthiness indicated by the labels. When the FOP labels show 'less healthy' for those expensive and perceived as 'healthy' products, consumers will update their prior belief about its healthiness and be more likely to drop the intuition 'expensive=healthiness' in decision-making and respond to a greater extent.
43 studies on the registry are indexed under Consumer Behavior; 7 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 164 across 33 interventional studies indexed under Consumer Behavior.
Browse Consumer Behavior studies →Duke-NUS Graduate Medical School is the lead sponsor of 63 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion criteria:
Participants will read a hypothetical scenario about ordering a meal for a coworker. Participants will be told that their coworker has no dietary restrictions and is trying to eat healthier. They will be presented with two similar restaurant meal options, one priced higher than the other, with randomized assignments. In the label condition, a nutritional label for healthy foods, called the Healthy Choice Symbol adopted in Singapore, will be provided with an explanation of the labelling system. For both label and non-label conditions, participants will be asked to assess the healthfulness of each option using a standard 5-point scale (1-least healthy to 5-healthiest). Participants will then be asked to indicate which option to order for their coworker. Participants will be randomly assigned to one in four experimental arms.
Behavioral: Positively framed FOP labels (present versus absent) x Price (high versus low)
Participants will read a hypothetical cover story about a new brand of a grocery item with generic health claims and see pictures of different flavors of this brand. Participants will be randomly assigned to either an average or a premium price condition and informed about the average price of other brands of the same item. They will be asked to indicate their perceived relative healthiness of the product compared to the products in other brands on a 5-point scale (1- least healthy to 5- healthiest). After assessment, they will see a high-grade label (grade A), low-grade label (grade D), or no label. For those exposed to labels, they will be given an explanation of the label and asked to indicate their perceived relative healthiness of the product again. In the end, all participants will indicate their intention to purchase items on a 7-point scale (1: least likely - 7: most likely). Participants will be assigned to one in six experimental arms.
Behavioral: Graded FOP labels (no label vs. high rating (grade A) vs. low rating (grade D)) x Price (average vs. premium)
The intervention combines either a front-of-pack (FOP) label that frames high nutrition or no FOP label with price variation. Products are randomly assigned to either receive a positively-framed FOP label or no label, and to either a high or a low price. This yields four experimental arms: 1. Positively framed FOP label with high price 2. Positively framed FOP label with low price 3. No label with high price 4. No label with low price
The intervention combines either a graded front-of-pack (FOP) labelling or no FOP labelling with price variation. Products are randomly assigned to either receive a graded label or no label, and to either a premium or an average price. This yields six experimental arms: 1. High grade (A) with premium price 2. Low grade (D) with premium price 3. No label with premium price 4. High grade (A) with average price 5. Low grade (D) with average price 6. No label with average price
Consumers behavior
Study 1: Participants achieve a response by choosing between two menu food items they would purchase for their co-worker in online experimental platform. Study 2: Participants rate their intention to purchase grocery items on a 7-point scale (1 = least likely, 7 = most likely) in online experimental platform.
Time frame: Participants are expected to complete the online experiment in one sitting (within 24 hours). If they are disconnected from the survey platform, they are allowed up to two attempts to resume, with access to the platform disabled after 48 hours.
No study locations are listed for this record.
Start is estimated for Oct 2025; primary completion for Dec 2025, 2 months later.
Of 21 interventional studies with no phase under Consumer Behavior, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 14. This study's planned 2 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke-NUS Graduate Medical School